Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression

Journal of Psychopharmacology

Volumn 24, Issue 12, 2010, Pages 1755-1763

  Lee, M S ^a,a,b   Kang, R H ^a,b   Chang, H S ^a,b   Wong, M L ^c   Choi, M J ^a,b   Park, J Y ^a   Lee, H Y ^a,b   Jung, I K ^a   Joe, S H ^a   Kim, L ^a   Kim, S H ^a   Kim, Y K ^a   Han, C S ^a   Ham, B J ^d   Lee, H J ^a   Ko, Y H ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Hallym University   (South Korea)

Author keywords

brain derived neurotrophic factor; gene polymorphisms; major depression; mirtazapine; treatment response

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MIRTAZAPINE;

ADULT; ARTICLE; BDNF GENE; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENE; GENOTYPE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROMOTER REGION; SOUTH KOREA; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER, MAJOR; GENOTYPE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; POLYMORPHISM, GENETIC; REPUBLIC OF KOREA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 78650079772     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109105457     Document Type: Article

References (48)

1. Altar, CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20: 59-61.
2. Buchner, A., Faul, F., Erdfelder, E. (1996) G-Power: A Priori, Post-Hoc, and Compromise Power Analyses for the Macintosh (Version 2.1.1). Trier: University of Trier.
3. Chen, B., Dowlatshahi, D., MacQueen, GM, Wang, JF, Young, LT (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50: 260-265.
4. Chen, ZY, Patel, PD, Sant, G., Meng, CX, Teng, KK, Hempstead, BL, et al. (2004) Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 24: 4401-4411.
5. Choi, MJ, Kang, RH, Lim, SW, Oh, KS, Lee, MS (2006) Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res 1118: 176-182.
6. Coyle, JT, Duman, RS (2003) Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38: 157-160.
7. De Boer, T. (1995) The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. Int Clin Psychopharmacol 10: 19-23.
8. De Boer, T., Ruigt, GSF (1995) The selective 2-adrenoceptor antagonist mirtazapine (Org 3770) enhances noradrenergic and 5-HT1A mediated serotonergic neurotransmission. CNS Drugs 4: 29-38.
9. De Boer, T., Ruigt, GSF, Berendsen, HHG (1995) The alpha2-selective adrenoceptor antagonist org 3770 (mirtazapine, Remeron) enhances noradrenergic and serotonergic transmission. Hum Psychopharmacol 10: S107 - S118.
10. De Montigny, C., Haddjeri, N., Mongeau, R., Blier, P. (1995) The effects of mirtazapine on the interactions between central noradrenergic and serotonergic systems. CNS Drugs 4: 13-17.
11. Delgado, PL, Miller, HL, Salomon, RM, Licinio, J., Heninger, GR, Gelenberg, AJ, et al. (1993) Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull 29: 389-396.
12. Duman, RS (2002) Synaptic plasticity and mood disorders. Mol Psychiatry 7: S29 - S34.
13. Duman, RS, Charney, DS (1999) Cell atrophy and loss in major depression. Biol Psychiatry 45: 1083-1084.
14. Duman, RS, Heninger, GR, Nestler, EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-606.
15. Fawcett, J., Barkin, RL (1998) Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 51: 267-285.
16. Frank, E., Prien, RF, Jarrett, RB, Keller, MB, Kupfer, DJ, Lavori, PW, et al. (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48: 851-855.
17. Gervasoni, N., Aubry, JM, Bondolfi, G., Osiek, C., Schwald, M., Bertschy, G., et al. (2005) Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51: 234-238.
18. Gorwood, P. (1999) Genetic association studies in behavioral neuro-science. In: Cruzio, W, Gerlai, R (eds). Handbook of Molecular Genetic Techniques for Brain and Behavior Research. Amsterdam: Elsevier, pp. 113-121.
19. Haddjeri, N., Blier, P., de Montigny, C. (1995) Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine. Int Clin Psychopharmacol 10: 11-17.
20. Hong, CJ, Yu, YW, Lin, CH, Tsai, SJ (2003) An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci Lett 349: 206-208.
21. Jones, KR, Reichardt, LF (1990) Molecular cloning of a human gene that is a member of the nerve growth factor family. Proc Natl Acad Sci U S A 87: 8060-8064.
22. Kim, JW (2003) Association study and the population admixture. Human Neurobehavioral Genetics in the 21st Century. Seoul, Korea: Korean Society of Biological Psychiatry.
23. Lang, UE, Hellweg, R., Kalus, P., Bajbouj, M., Lenzen, KP, Sander, T., et al. (2005) Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 180: 95-99.
24. Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masiakowski, P., et al. (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341: 149-152.
25. Maisonpierre, PC, Le Beau, MM, Espinosa III, R., Ip, NY, Belluscio, L., de la Monte, SM, et al. (1991) Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 10: 558-568.
26. Mamounas, LA, Blue, ME, Siuciak, JA, Altar, CA (1995) Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 15: 7929-7939.
27. Mössner, R., Daniel, S., Albert, D., Heils, A., Okladnova, O., Schmitt, A., et al. (2000) Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF). Neurochem Int 36: 197-202.
28. Mowla, SJ, Farhadi, HF, Pareek, S., Atwal, JK, Morris, SJ, Seidah, NG, et al. (2001) Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J Biol Chem 276: 12660-12666.
29. Nestler, EJ, Barrot, M., DiLeone, RJ, Eisch, AJ, Gold, SJ, Monteggia, LM (2002 a) Neurobiology of depression. Neuron 34: 13-25.
30. Nestler, EJ, Gould, E., Manji, H., Buncan, M., Duman, RS, Greshenfeld, HK, et al. (2002 b) Preclinical models: status of basic research in depression. Biol Psychiatry 52: 503-528.
31. Nutt, DJ (2002) Tolerability and safety aspects of mirtazapine. Hum Psychopharmacol 17: S37 - S41.
32. Oroszi, G., Lapteva, L., Davis, E., Yarboro, CH, Weickert, T., Roebuck-Spencer, T., et al. (2006) The Met66 allele of the functional Val66-Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus. Ann Rheum Dis 65: 1330-1335.
33. Ozçelik, T., Rosenthal, A., Francke, U. (1991) Chromosomal mapping of brain-derived neurotrophic factor and neurotrophin-3 genes in man and mouse. Genomics 10: 569-575.
34. Pröschel, M., Saunders, A., Roses, AD, Müller, CR (1992) Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). Hum Mol Genet 1: 353.
35. Quitkin, FM, Taylor, BP, Kremer, C. (2001) Does mirtazapine have a more rapid onset than SSRIs ? J Clin Psychiatry 62: 358-361.
36. Rothman, KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1: 43-46.
37. Sen, S., Nesse, RM, Stoltenberg, SF, Li, S., Gleiberman, L., Chakravarti, A., et al. (2003) A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28: 397-401.
38. Serretti, A., Lorenzi, C., Cusin, C., Zanardi, R., Lattuada, E., Rossini, D., et al. (2003) SSRIs antidepressant activity is influenced by G beta 3 variants. Eur Neuropsychopharmacol 13: 117-122.
39. Shimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., et al. (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54: 70-75. (Pubitemid 36776725)
40. Siuciak, JA, Altar, CA, Wiegand, SJ, Lindsay, RM (1994) Antinociceptive effect of brain-derived neurotrophic factor and neurotrophin-3. Brain Res 633: 326-330.
41. Smith, MA, Makino, S., Kvetnansky, R., Post, RM (1995) Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15: 1768-1777.
42. Thompson, C. (2002) Onset of action of antidepressants: results of different analyses. Hum Psychopharmacol 17: S27 - S32.
43. Tsai, SJ, Cheng, CY, Yu, YW, Chen, TJ, Hong, CJ (2003) Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am J Med Genet B Neuropsychiatr Genet 123B: 19-22.
44. Vaidya, VA, Marek, GJ, Aghajanian, GK, Duman, RS (1997) 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J Neurosci 17: 2785-2795.
45. van Praag, HM, Asnis, GM, Kahn, RS, Brown, SL, Korn, M., Friedman, JM, et al. (1990) Monoamines and abnormal behaviour. A multi-aminergic perspective. Br J Psychiatry 157: 723-734.
46. Ventimiglia, R., Mather, PE, Jones, BE, Lindsay, RM (1995) The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 7: 213-222.
47. Watanabe, Y., Gould, E., McEwen, BS (1992) Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons. Brain Res 588: 341-345.
48. Zetterström, TS, Pei, Q., Madhav, TR, Coppell, AL, Lewis, L., Grahame-Smith, DG (1999) Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 38: 1063-1073.